MAN790 Strategic Management

Action Learning Project: Group 19

Rahul Baranwal (Team Leader)

Amit Deb

Vijay Shetty

Devasis Pati

Ankur Dubey

MAN790 Strategic Management

Project Group - 19
 Introduction
MISSION
“Our mission is to become the world’s most valued company to patients,
customers, colleagues, investors, business partners, and the
communities where we work and live.”
VISION
“Innovate to bring therapies to patients that significantly
improve their lives”
VALUES
Excellence, Equity and Joy
• Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New
York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin
Charles F. Erhart (1821–1891)
• Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's
largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($37 billion in 2022 revenues), Nirmatrelvir/ritonavir ($18 billion in 2022
revenues), Apixaban ($6 billion in 2022 revenues), a pneumococcal conjugate vaccine ($6 billion in 2022 revenues), and Palbociclib ($5
billion in 2022 revenues). In 2022, 42% of the company's revenues came from the United States, 8% from Japan, and 50% from other
countries
• Pfizer was a component of the Dow Jones Industrial Average stock market index from 2004 to August 2020. The company ranks 43rd on the
Fortune 500 and 43rd on the Forbes Global 2000
MAN790 Strategic Management
Project Group - 19
Which overall trends can be observed?

Several overall trends can be observed in the pharmaceutical industry

• Increasing emphasis on specialty drugs: Specialty drugs, used to treat complex and chronic medical conditions, are
becoming increasingly important in the pharmaceutical industry. These drugs tend to have higher profit margins than
traditional medications but also require significant investments in research and development
• The growing importance of emerging markets: Emerging markets such as China, India, and Brazil are becoming increasingly
important for pharmaceutical companies, as these countries have large populations and increasing healthcare spending.
Companies are investing in these markets by establishing local manufacturing and distribution networks and developing
drugs tailored to the needs of these markets
• Rising costs and complexity of drug development: The cost and complexity of drug development are increasing as
companies focus on developing more specialized drugs that require extensive research and clinical testing. This has led to
longer development times and higher costs, making it more difficult for smaller firms to compete

MAN790 Strategic Management

Project Group - 19
Current pharmaceutical trends may add more cost, complexity, and risk, with these forces compounding one another.

MAN790 Strategic Management

Project Group - 19
• The growing role of technology: Technology is playing an increasingly important role in the pharmaceutical industry, as
companies use tools such as artificial intelligence, machine learning, and data analytics to identify new drug targets and
optimize drug development processes. Companies are also using digital to increase the effectiveness of healthcare delivery
and improve patient outcomes
• Increasing scrutiny of drug pricing: The high cost of drugs has become a significant issue in many countries, leading to
increased scrutiny of drug pricing practices by governments and other stakeholders. This has led to efforts to control drug
prices through price controls, reference pricing, and value-based pricing
• The pharmaceutical industry faces numerous challenges and opportunities as companies seek to navigate a rapidly changing
market environment and bring new and innovative products to market

MAN790 Strategic Management

Project Group - 19
 References
 https://bstrategyhub.com/pfizer-mission-statement-vision-core-values-analysis/
 https://en.wikipedia.org/wiki/Pfizer
 https://
services.hbsp.harvard.edu/api/courses/978674/items/W19390-PDF-ENG/sclinks/cb55ad5e930ff39264b319bb67b1088d
 https://
www.mckinsey.com/capabilities/operations/our-insights/emerging-from-disruption-the-future-of-pharma-operations-stra
tegy

MAN790 Strategic Management

Project Group - 19
MAN790 Strategic Management
Project Group - 19